> Charles River Laboratories today announced that its contract manufacturing revenues were down in the first quarter. Release
> India's Nutraplus says it will build to API plants. Report
> South Korea's Green Cross said it intends to build a cell therapy manufacturing facility at the Guian New Area in the Guizhou province of China. Release